Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123491262 | 12349126 | 2 | F | 2003 | 20160805 | 20160509 | 20160812 | EXP | BR-ASTRAZENECA-2016SE49817 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160813 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123491262 | 12349126 | 1 | PS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 3.6 | MG | IMPLANT | /month | |||||||
| 123491262 | 12349126 | 2 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 3.6 | MG | IMPLANT | /month | |||||||
| 123491262 | 12349126 | 3 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 3.6 | MG | IMPLANT | /month | |||||||
| 123491262 | 12349126 | 4 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 3.6 | MG | IMPLANT | /month | |||||||
| 123491262 | 12349126 | 5 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 10.8 | MG | IMPLANT | /month | |||||||
| 123491262 | 12349126 | 6 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 10.8 | MG | IMPLANT | /month | |||||||
| 123491262 | 12349126 | 7 | C | CALCIUM | CALCIUM | 1 | Oral | 0 | |||||||||||
| 123491262 | 12349126 | 8 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 123491262 | 12349126 | 9 | C | COLLAGEN | COLLAGEN | 1 | 0 | ||||||||||||
| 123491262 | 12349126 | 10 | C | RADIOTHERAPY | RADIATION THERAPY | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123491262 | 12349126 | 1 | Prostate cancer |
| 123491262 | 12349126 | 2 | Prostatic specific antigen increased |
| 123491262 | 12349126 | 3 | Prostate cancer |
| 123491262 | 12349126 | 4 | Prostatic specific antigen increased |
| 123491262 | 12349126 | 5 | Prostate cancer |
| 123491262 | 12349126 | 6 | Prostatic specific antigen increased |
| 123491262 | 12349126 | 7 | Osteopenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123491262 | 12349126 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123491262 | 12349126 | Activities of daily living impaired | |
| 123491262 | 12349126 | Arthralgia | |
| 123491262 | 12349126 | Asthenia | |
| 123491262 | 12349126 | Chest discomfort | |
| 123491262 | 12349126 | Fall | |
| 123491262 | 12349126 | Gait disturbance | |
| 123491262 | 12349126 | Hypoaesthesia | |
| 123491262 | 12349126 | Muscular weakness | |
| 123491262 | 12349126 | Osteopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123491262 | 12349126 | 1 | 2001 | 2003 | 0 | |
| 123491262 | 12349126 | 2 | 2001 | 2003 | 0 | |
| 123491262 | 12349126 | 3 | 201510 | 201602 | 0 | |
| 123491262 | 12349126 | 4 | 201510 | 201602 | 0 | |
| 123491262 | 12349126 | 5 | 20160504 | 0 | ||
| 123491262 | 12349126 | 6 | 20160504 | 0 | ||
| 123491262 | 12349126 | 7 | 2015 | 0 |